News

As more and more avian flu cases are identified in the UK, actions to slow the spread are being taken. To read more about this outbreak, read the linked article.

Clinical trials for a new ebola vaccine are set to begin by the Jenner Institute. A total of 26 patients will receive a dose of the vaccine, which was developed using viral vector technology, as seen with the AstraZeneca COVID-19 vaccine.

Interested in learning more about what caused a Yellow Fever outbreak in Brazil after 80 years? This article provides clues using demographic groups to discuss potential theories,

A research group at the Singapore-MIT Alliance for Research and Technology (SMART) created a paper-based test using a drop of blood to rapidly detect COVID-19 antibodies. This 10 minute test could be beneficial in schools and help determine individuals need for a COVID-19 vaccine booster. Read more about the test SMART developed by reading the full article.

Developers at iVAX may have a solution to cold-chain supply issues when it comes to vaccine distribution in developing nations. Click the blue box to read more about iVAX's modular technology.

Chronic wasting disease (CWD), which is "a contagious and fatal neurological disorder", has been detected in Idaho for the first time in their deer population. Through the states CWD monitoring program, hunters can voluntarily submit lymph nodes to test deer they have shot while hunting. Read more on this story by clicking the blue box.

According to the CDC, in 2020, anthrax associated with pneumonia caused illness in two individuals working in welding and metalworking, one of which was fatal. To read more about anthrax and its association to the welding and metalworking communities, click the blue button.

Hospital-based infections, or hospital acquired infections are not uncommon. The University of Pittsburgh School of Medicine has teamed up with Carnegie Melon to track and prevent hospital infections using artificial intelligence.

Just as monoclonal antibody treatment has been made available for COVID-19 patients, the US National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID), has completed a monoclonal antibody trial in preventing malaria. Malaria remains a critical health burden in sub-Saharan Africa, which some say has caused more deaths than the ongoing COVID-19 pandemic.

Maryland, USA has reported a case of monkeypox, a virus known for being in the same family as smallpox. The individual, who recently returned from Nigeria, is currently in isolation and will be monitored for 21 days.